Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2014
08/19/2014US8808999 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
08/19/2014US8808771 Active ingredient delivery system with an amorphous metal salt as carrier
08/19/2014US8808764 Methods and compositions for increasing growth hormones
08/19/2014US8808763 Methods for improving sleep efficiency in healthy human beings
08/19/2014US8808755 Hydrogen peroxide-based skin disinfectant
08/19/2014US8808749 Polymer conjugate of bioactive substance having hydroxy group
08/19/2014US8808741 Tamper resistant dosage forms
08/19/2014US8808718 Hypertonic organic acid or salt thereof disinfectant composition and its use in dental treatment
08/19/2014US8808716 Topical foam composition
08/19/2014US8808708 Multivalent pneumococcal polysaccharide-protein conjugate composition
08/19/2014US8808687 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
08/19/2014US8808681 Crosslinked, degradable polymers and uses thereof
08/19/2014US8808679 Auristatin compounds and conjugates thereof
08/19/2014US8808669 Gastroretentive, extended release composition of therapeutic agent
08/19/2014US8808665 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
08/19/2014CA2795275C Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
08/19/2014CA2709865C Method for improved breast milk feeding to reduce the risk of allergy
08/19/2014CA2675231C A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof
08/19/2014CA2651285C Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
08/19/2014CA2646598C Peptide-peptidase inhibitor conjugates and methods of using same
08/19/2014CA2596529C Hydrophilic biocompatible adhesive formulations and uses
08/19/2014CA2591970C Polyethylene glycolated superoxide dismutase mimetics
08/19/2014CA2580628C Berry oils and products
08/19/2014CA2574437C Infusion and injection solution of levodopa
08/19/2014CA2475338C Treatment of ophthalmic disorders using urea and urea derivatives
08/19/2014CA2434409C Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
08/19/2014CA2411596C Therapeutic agents - ii
08/14/2014WO2014124329A1 Nanoparticles for drug delivery
08/14/2014WO2014124322A1 Nanoparticles for drug delivery
08/14/2014WO2014124317A1 Analgesic conjugates
08/14/2014WO2014124304A1 System and method using precious-metal nanoparticle contrast agent for microwave medical imaging
08/14/2014WO2014124258A2 Specific sites for modifying antibodies to make immunoconjugates
08/14/2014WO2014124132A1 Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
08/14/2014WO2014124096A1 Stable glucagon formulations
08/14/2014WO2014123935A1 Biodegradable and clinically-compatible nanop articles as drug delivery carriers
08/14/2014WO2014123791A1 Nanoparticles containing a taxane and their use
08/14/2014WO2014123612A1 Methods of treating melanoma
08/14/2014WO2014122648A1 Positively charged polysaccharides for rna transfection
08/14/2014WO2014122444A1 Permeation enhanced active-carrying nanoparticles
08/14/2014WO2014122431A1 Biospecific agents for bone
08/14/2014WO2014122024A1 Topical antifungal composition for treating onychomycosis
08/14/2014US20140228840 Composite compositions and applications thereof
08/14/2014US20140228747 Recessed Bolus
08/14/2014US20140228516 Bispecific intracellular delivery vehicles
08/14/2014US20140228452 Hydroxypolyamide gel forming agents
08/14/2014US20140228451 Cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
08/14/2014US20140228449 Hybrid polymeric materials for medical applications and preparation thereof
08/14/2014US20140228444 Otic composition for companion animals
08/14/2014US20140228397 Propellant-free aerosol formulation for inhalation
08/14/2014US20140228391 Anise Flavored Medication
08/14/2014US20140228389 Dry powder compound formulations and uses thereof
08/14/2014US20140228364 Ophthalmic Compositions Comprising Prostaglandin F2 Alpha Derivatives and Hyaluronic Acid
08/14/2014US20140228326 Carbonate prodrugs and methods of using the same
08/14/2014US20140228318 Curcumin formulations and methods for making such formulations
08/14/2014US20140228309 Stabilized formulation for oral administration of therapeutic agents and related methods
08/14/2014US20140228308 Formulations for the oral administration of therapeutic agents and related methods
08/14/2014US20140228280 Low impurity content caspofungin preparation, method for preparing same, and use thereof
08/14/2014US20140227370 Polysaccharide fibres for wound dressings
08/14/2014US20140227369 Silver Oxide Formulations
08/14/2014US20140227366 Carrier material for improving the persistance of biocides
08/14/2014US20140227359 Diketopiperazine salts for drug delivery and related methods
08/14/2014US20140227355 Pharmaceutical composition for oral administration with a statin
08/14/2014US20140227354 Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
08/14/2014US20140227345 Components for producing amphoteric liposomes
08/14/2014US20140227344 Cell Penetrating Peptides for Intracellular Delivery of Molecules
08/14/2014US20140227340 Fibers Comprising Poorly Soluble Drugs and/or Proteins
08/14/2014US20140227330 Capsule whose envelope is separately imperceptible during the topical use thereof
08/14/2014US20140227327 Injectable Cryogel Vaccine Devices and Methods of Use Thereof
08/14/2014US20140227316 Beta-lactam compounds for enhancing t cell-mediated immune responses
08/14/2014US20140227299 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
08/14/2014US20140227298 Tubulysin compounds, methods of making and use
08/14/2014US20140227297 Targeted theranostics
08/14/2014US20140227296 Modified glycolipids and methods of making and using the same
08/14/2014US20140227295 Tubulysin compounds, methods of making and use
08/14/2014US20140227274 Prevention and Treatment of Amyloidogenic Disease
08/14/2014US20140227264 Drug fusions and conjugates with extended half life
08/14/2014US20140227235 Cartilage cell treatment comprising collagen, hyaluronic acid derivative, and stem cell derived from mammal umbilical cord
08/14/2014US20140227223 Pegylated Interleukin-10
08/14/2014US20140227218 Pharmaceutical Compositions of Conjugates Formed From Polymer Derivatives Having Particular Atom Arrangements
08/14/2014US20140227188 Compositions and Methods for Using Cathepsin E Cleavable Substrates
08/14/2014US20140227185 Glutathione-based drug delivery system
08/14/2014US20140227180 Antibody-sn-38 immunoconjugates with a cl2a linker
08/14/2014US20140227179 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/14/2014US20140227178 Humanized Anti-HLA-DR Antibodies
08/14/2014US20140227177 Scanning Suspension Comprising a Particle with a Diameter of at least 1 Micrometer
08/14/2014US20140227174 Skin permeating and cell entering (space) peptides and methods of use therefor
08/14/2014DE112012003996T5 Caspofunginpräparat mit geringem Verunreinigungsgehalt, Verfahren zu seiner Herstellung und seine Verwendung Caspofunginpräparat with low impurity content, process for its preparation and its use
08/13/2014EP2764875A1 Process for preparing a stable pharmaceutical composition comprising dexketoprofen trometamol
08/13/2014EP2764861A1 Liposome composite body
08/13/2014EP2763946A1 Method for preparing 1,2,3-trimethoxypropane, uses thereof, and compositions including said 1,2,3-trimethoxypropane
08/13/2014EP2763656A1 Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis
08/13/2014EP2763654A1 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
08/13/2014EP2763525A1 Stabilisation of polypeptides
08/13/2014CN103987718A 作为非对称二聚体pbd化合物用于内含在靶向结合物中的吡咯并苯并二氮杂卓 As a non-symmetric dimers pbd compounds for inclusion in the targeting conjugate pyrrolo benzodiazepine
08/13/2014CN103987407A 吡咯并苯并二氮杂卓及其偶联物 Pyrrolo benzodiazepines and their conjugates
08/13/2014CN103987406A 含有激酶抑制剂的组合物 Kinase inhibitor composition comprising
08/13/2014CN103987380A 颗粒及包覆造粒物 Particles and coated granules
08/13/2014CN103987378A 硅氧烷涂覆的植入物 Silicone coated implants
08/13/2014CN103987358A 甲状腺激素t3和/或t4的单次剂量药物制剂 Single dose of the pharmaceutical preparation of thyroid hormone t3 and / or t4 of
08/13/2014CN103980717A 一种明胶共混天然多糖改性胶囊 A gelatin capsule blend of natural polysaccharides modified
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 1712